Key facts
- It has raised $6.6M across 5 recorded rounds; the latest was Seed Round ($2.5M) in Jul 2022.
- Notable investors include MedTech Innovator, 11 Tribes Ventures, Colchuck, Davis Wright Tremaine, Flywheel Investment Conference — 9 tracked in total.
- BrainSpace has filed 5 Form Ds with the SEC since 2021, most recently Aug 2023 ($2.2M sold to 12 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for BrainSpace
Funding rounds
5 roundsAbout BrainSpace
Developer of neurocritical automated connected devices designed to protect the brain and spine after trauma, surgery, or neurodegeneration. The company's devices are provided to reduce the long-term disability caused by brain damage and are aimed at offering a less labor-intensive and lower-risk brain pressure management with clinical evaluation of digital biomarkers, enabling patients with trauma, dementia, and brain injury to get treated with the help of technology.
- Sector
- Healthcare
- HQ
- Bothell, WA, United States
- Founded
- 2021
- Employees
- 10
- Website
- brainspacemed.com/
- Ownership
- Privately Held (backing)
BrainSpace doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrainSpace shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrainSpace in its N-PORT filings yet. We sweep new filings monthly.